Matches in Wikidata for { <http://www.wikidata.org/entity/Q94934519> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q94934519 description "clinical trial" @default.
- Q94934519 description "ensayo clínico" @default.
- Q94934519 description "ensayu clínicu" @default.
- Q94934519 description "klinisch onderzoek" @default.
- Q94934519 description "клінічне випробування" @default.
- Q94934519 description "կլինիկական փորձարկում" @default.
- Q94934519 description "临床试验" @default.
- Q94934519 name "A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)" @default.
- Q94934519 name "A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)" @default.
- Q94934519 type Item @default.
- Q94934519 label "A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)" @default.
- Q94934519 label "A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)" @default.
- Q94934519 prefLabel "A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)" @default.
- Q94934519 prefLabel "A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)" @default.
- Q94934519 P1132 Q94934519-48E2E1FA-BE0C-4397-A0D8-8537D366308B @default.
- Q94934519 P1476 Q94934519-69018DA8-BC2A-4A4F-85ED-CA5E07BC355B @default.
- Q94934519 P2899 Q94934519-01FE820F-0285-46B1-9A60-7112BF5CE2FB @default.
- Q94934519 P3098 Q94934519-C6D66038-9FA6-401F-86D5-ECC67F912A2E @default.
- Q94934519 P31 Q94934519-A55F9C1C-AF7A-4C1C-AA35-152E7894B42A @default.
- Q94934519 P4135 Q94934519-3016DBE8-B087-4716-85E0-7705D4F4CBC3 @default.
- Q94934519 P4844 Q94934519-8E392114-CC79-416A-905A-424F4372398F @default.
- Q94934519 P580 Q94934519-137ADA4D-D92B-4093-A03C-160AC72BA7E8 @default.
- Q94934519 P582 Q94934519-ACD3DF0D-B81A-40E8-B438-8A8CCAF9E7B1 @default.
- Q94934519 P8005 Q94934519-77CF3A90-922C-4E37-92B6-DA5F58D67252 @default.
- Q94934519 P8363 Q94934519-977C97DC-EC34-4947-BB96-522B0DEDFBC7 @default.
- Q94934519 P1132 "+216" @default.
- Q94934519 P1476 "A Randomized, National Multicenter Clinical Study Comparing Pembrolizumab With Maintenance Therapy Every 3 Weeks and Every 6 Weeks for First-line Treatment of PD-L1 ≥1% Metastatic Non-small Cell Lung Cancer (NSCLC)" @default.
- Q94934519 P2899 "+18" @default.
- Q94934519 P3098 "NCT04393883" @default.
- Q94934519 P31 Q30612 @default.
- Q94934519 P4135 "+25" @default.
- Q94934519 P4844 Q13896859 @default.
- Q94934519 P580 "2020-07-01T00:00:00Z" @default.
- Q94934519 P582 "2022-07-01T00:00:00Z" @default.
- Q94934519 P8005 Q76649708 @default.
- Q94934519 P8363 Q78089383 @default.